These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry. Olveira C, Padilla A, Martínez-García MÁ, de la Rosa D, Girón RM, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Casas F, Cordovilla R, de Gracia J. Arch Bronconeumol; 2017 Jul; 53(7):366-374. PubMed ID: 28118936 [Abstract] [Full Text] [Related]
4. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics. Venning V, Bartlett J, Jayaram L. Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369 [Abstract] [Full Text] [Related]
5. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814 [Abstract] [Full Text] [Related]
12. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Roche N, Kouassi B, Rabbat A, Mounedji A, Lorut C, Huchon G. Respiration; 2007 Jun; 74(1):19-25. PubMed ID: 16675894 [Abstract] [Full Text] [Related]
14. Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography. Tufvesson E, Markstad H, Bozovic G, Ekberg M, Bjermer L. Int J Chron Obstruct Pulmon Dis; 2017 Jun; 12():3211-3219. PubMed ID: 29138549 [Abstract] [Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N. Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [Abstract] [Full Text] [Related]
18. Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: A population-based study. Shkeiri R, Saliba W, Stein N, Najjar R, Weber G, Dror SK, Mishan PS, Adir Y, Shteinberg M. Respir Med; 2021 Jul; 185():106487. PubMed ID: 34139580 [Abstract] [Full Text] [Related]
19. Bronchiectasis in Türkiye: Data from a Multicenter Registry (Turkish Adult Bronchiectasis Database). Çakır Edis E, Çilli A, Kızılırmak D, Şakar Coşkun A, Güler N, Çiçek S, Sevinç C, Çoban Ağca M, Gülmez İ, Çağlayan B, Kabak M, Özgün Niksarlıoğlu EY, Köktürk N, Sayıner A, TEBVEB researchers. Balkan Med J; 2024 May 03; 41(3):206-212. PubMed ID: 38700365 [Abstract] [Full Text] [Related]
20. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ. Lancet Respir Med; 2014 Dec 03; 2(12):988-96. PubMed ID: 25458200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]